The reduction in colon cancer development was linked to decreased levels of pro-inflammatory cytokines (IL-6, TNF-α) in macrophages and inhibition of the EGFR/ERK pathway, which regulates cancer cell proliferation. Here, IL6 is linked to malignant colon neoplasm.